Pharmacokinetics and pharmacodynamics of sofosbuvir and ledipasvir for the treatment of hepatitis C

ANTONIO RIVERO ROMÁN2026-01-292026-01-29201710.1080/17425255.2017.12557252-s2.0-84994904470https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/27589PharmacologyToxicologyPharmacokinetics and pharmacodynamics of sofosbuvir and ledipasvir for the treatment of hepatitis Cresearch article